You are on Trendlyne United States.
Click here
to go to India website or make
United States
as your default
Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Data Downloader
Events Calendar
Explore
FAQs
Widgets
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Kala Pharmaceuticals Inc
Swot
Kala Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Kala Pharmaceuticals Inc has 7 Strengths, 15 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(7)
Weakness
(15)
Opportunity
(2)
Threats
(2)
Others
(0)
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Increasing profits every quarter for the past 3 quarters
Stock with Low PE (PE < = 10)
Promoter decreasing their shareholding
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Top Losers
Near 52 Week Low
Low Piotroski Score : Companies with weak financials
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
Red Flags: Weakening Technicals and Share Price Decline
